ECOG 1308: A phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP).
暂无分享，去创建一个
C. Chung | A. Cmelak | R. Ferris | W. Westra | J. Bauman | J. Gilbert | A. Colevas | Weiqiang Zhao | B. Burtness | M. Gillison | L. Wagner | S. Marur | Ju-Whei Lee | B. Jahagirdar | D. Trevarthen